+86-571-85081802     info@multin.cn
Anti-cancer Drug Docetaxel Anhydrous Cas No: 114977-28-5
Home » Products » Pharmaceutical Intermediate » Anti-cancer Drug Docetaxel Anhydrous Cas No: 114977-28-5

Product Category

Contact Us

 Tel: +86-571-85081802
  Phone: +86-13655719091
 E-mail: info@multin.cn
  Add: Room 321,lingjun Mansion South,the 10th Chaowang Road,xiacheng District,hangzhou City,zhejiang Province China

Anti-cancer Drug Docetaxel Anhydrous Cas No: 114977-28-5 Anti-cancer Drug Docetaxel Anhydrous Cas No: 114977-28-5
Anti-cancer Drug Docetaxel Anhydrous Cas No: 114977-28-5 Anti-cancer Drug Docetaxel Anhydrous Cas No: 114977-28-5
Anti-cancer Drug Docetaxel Anhydrous Cas No: 114977-28-5 Anti-cancer Drug Docetaxel Anhydrous Cas No: 114977-28-5
Anti-cancer Drug Docetaxel Anhydrous Cas No: 114977-28-5 Anti-cancer Drug Docetaxel Anhydrous Cas No: 114977-28-5

loading

Anti-cancer Drug Docetaxel Anhydrous Cas No: 114977-28-5

Share to:
sharethis sharing button
Product name Docetaxel anhydrous
CAS No 114977-28-5
MF C 43H53NO14
MW 807.89g/mol
Appearance White or almost white crystalline powder
Assay 99%
  • CAS 114977-28-5

  • MT

  • 114977-28-5

  • 114977-28-5

Availability:

            Supply Top Grade Docetaxel Intermediates Powder CAS 114977-28-5

Product nameDocetaxel anhydrous

CAS No114977-28-5

MFC 43H53NO14

MW807.89g/mol

AppearanceWhite or almost white crystalline powder

Assay99%



Top-Quality-Tenofovir-disoproxil-fumarate-cas-202138

                                          

111 

 Function

1.It is a clinically well established anti-mitotic chemotherapy medication (that is, it interferes with cell division).
2.It is used mainly for the treatment of breast, ovarian, and non-small cell lung cancer.
3.It has an FDA approved claim for treatment of patients who have locally advanced, or metastatic breast or non small-cell lung cancer who have undergone anthracycline based chemotherapy and failed to stop cancer progression or relapsed. An European approval docetaxel for use in hormone-refractory prostate cancer. 
4.It is considered better than doxorubicin, paclitaxel and fluorouracil as a cytotoxic antimicrotubule. 

Our services

1. Supply top quality products with a reasonable price.

2. Arrange the orders and shipping with your requests on time, According to the different countries export policy provide complete customs clearance documents.

3. Samples can be arranged for testing and Unconditional assume responds.

4. Provide a price trend, ensure the clients can know about  marketing informations in time.


Packing and Shipping:


packing

packing1


Previous: 
Next: 

Related Products

OUR PRODUCTS

HOT LINKS

Copyright  2020 ZHEJIANG MULTINPHARMA CO.,LTD All Rights Reserved  浙ICP备17013806号-1  |  Technology by www.leadong.com